celastrol has been researched along with cadmium in 2 studies
Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (cadmium) | Trials (cadmium) | Recent Studies (post-2010) (cadmium) |
---|---|---|---|---|---|
885 | 1 | 741 | 37,999 | 84 | 18,071 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Dong, X; Huang, S; Liu, C; Liu, L; Wang, X; Xu, C; Yang, S; Zhang, H; Zhang, N; Zhang, R; Zhu, Y | 1 |
Chen, L; Dong, X; Gu, C; Hu, X; Huang, S; Ji, X; Liu, C; Wang, X; Xu, C; Zhang, H; Zhang, R | 1 |
2 other study(ies) available for celastrol and cadmium
Article | Year |
---|---|
Celastrol prevents cadmium-induced neuronal cell death by blocking reactive oxygen species-mediated mammalian target of rapamycin pathway.
Topics: Animals; Apoptosis; Cadmium; Cell Death; Dose-Response Relationship, Drug; Humans; Mitochondria; Neurons; Pentacyclic Triterpenes; Rats; Reactive Oxygen Species; Structure-Activity Relationship; TOR Serine-Threonine Kinases; Triterpenes; Tumor Cells, Cultured | 2017 |
Celastrol ameliorates Cd-induced neuronal apoptosis by targeting NOX2-derived ROS-dependent PP5-JNK signaling pathway.
Topics: Animals; Apoptosis; Cadmium; Drug Delivery Systems; Female; JNK Mitogen-Activated Protein Kinases; Membrane Glycoproteins; Mice; Mice, Inbred ICR; NADPH Oxidase 2; NADPH Oxidases; Neurons; Nuclear Proteins; Pentacyclic Triterpenes; Phosphoprotein Phosphatases; Rats; Reactive Oxygen Species; Tripterygium; Triterpenes | 2017 |